Analyst Ratings For Apollo Endosurgery (NASDAQ:APEN)
Today, Craig Hallum initiated coverage on Apollo Endosurgery (NASDAQ:APEN) with a Buy with a price target of $11.00.
There are 1 buy rating on the stock.
The current consensus rating on Apollo Endosurgery (NASDAQ:APEN) is Buy (Score: 3.00) with a consensus target price of $6.73 per share, a potential 0.37% downside.
Some recent analyst ratings include
- 7/24/2017-Craig Hallum initiated coverage with a Buy rating.
Recent Insider Trading Activity For Apollo Endosurgery (NASDAQ:APEN)
Apollo Endosurgery (NASDAQ:APEN) has insider ownership of 74.20% and institutional ownership of 16.11%.
- On 5/18/2017 Todd Newton, CEO, bought 2,121 with an average share price of $6.22 per share and the total transaction amounting to $13,192.62. View SEC Filing
- On 5/17/2017 William D Jr. Mcclellan, Director, bought 2,000 with an average share price of $6.33 per share and the total transaction amounting to $12,660.00. View SEC Filing
- On 5/11/2017 A/S Novo, Major Shareholder, sold 105,000 with an average share price of $5.63 per share and the total transaction amounting to $591,150.00. View SEC Filing
- On 12/12/2014 Daniel H Petree, Director, bought 10,000 with an average share price of $2.79 per share and the total transaction amounting to $27,900.00. View SEC Filing
- On 8/20/2014 Gary J G Atkinson, CFO, bought 5,000 with an average share price of $3.10 per share and the total transaction amounting to $15,500.00. View SEC Filing
- On 8/19/2014 Scott R Pancoast, CEO, bought 10,000 with an average share price of $3.00 per share and the total transaction amounting to $30,000.00. View SEC Filing
- On 8/18/2014 Scott R Pancoast, CEO, bought 10,000 with an average share price of $3.22 per share and the total transaction amounting to $32,200.00. View SEC Filing
Recent Trading Activity for Apollo Endosurgery (NASDAQ:APEN)
Shares of Apollo Endosurgery closed the previous trading session at 6.75 up +0.55 8.87% with 132,885 shares trading hands.